Company Filing History:
Years Active: 2015-2025
Title: Cedric Jozef Néotère Ververken: Innovator in CX3CR1-Binding Polypeptides
Introduction
Cedric Jozef Néotère Ververken is a notable inventor based in Merelbeke, Belgium. He has made significant contributions to the field of biotechnology, particularly in the development of CX3CR1-binding polypeptides. With a total of 6 patents to his name, Ververken's work has implications for therapeutic and diagnostic applications.
Latest Patents
Ververken's latest patents focus on nucleic acids encoding CX3CR1-binding polypeptides that comprise immunoglobulin single variable domains. The inventions relate to the preparation of these polypeptides, host cells capable of expressing them, and their various applications. These polypeptides are particularly relevant for prophylactic, therapeutic, and diagnostic purposes, showcasing the potential for significant advancements in medical science.
Career Highlights
Throughout his career, Ververken has worked with prominent companies in the biotechnology sector, including Boehringer Ingelheim International GmbH and Ablynx N.V. His experience in these organizations has allowed him to refine his expertise and contribute to innovative projects that push the boundaries of current scientific understanding.
Collaborations
Ververken has collaborated with notable professionals in his field, including Sanjaya Singh and Alisa K Waterman. These partnerships have likely enriched his research and development efforts, fostering an environment of innovation and creativity.
Conclusion
Cedric Jozef Néotère Ververken stands out as a significant figure in the realm of biotechnology, particularly through his work on CX3CR1-binding polypeptides. His contributions have the potential to impact various medical applications, making him a key inventor in his field.